Cited by 117Diabetes, Cardiovascular Risks, and LipoproteinsClinical Laboratory Practices and Quality ControlDiabetes Management and Research

Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population: HOMA-IR reference interval in Japanese

Open access
Yamada, Chizumi, Mitsuhashi, Toshitake, Hiratsuka, Noboru, Inabe, Fumiyo, Araida, Nami, Takahashi, Eiko·2011·Journal of Diabetes Investigation

Abstract

The aim of the present study was to establish a reference interval for homeostasis model assessment of insulin resistance (HOMA-IR) in a Japanese population based on the C28-A3 document from the Clinical and Laboratory Standards Institute (CLSI). We selected healthy subjects aged 20-79 years, with fasting plasma glucose < 100 mg/dL, body mass index < 25 kg/m(2) and alanine aminotransferase < 31 U/L. HOMA-IR values were log transformed, values beyond mean ± 3 standard deviations (SD) were truncated, and the mean ± 2 SD of log HOMA-IR values were taken as the upper and lower reference limits of HOMA-IR. We selected 2173 subjects as reference individuals, and 2153 subjects were used for analysis. The reference interval for HOMA-IR was established as between 0.4 and 2.4. This represents the first reference interval study for HOMA-IR that applies the stringent CLSI C28-A3 document. HOMA-IR ≥ 2.5 should be considered a reasonable indicator of insulin resistance in Japanese. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00113.x, 2011).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.2040-1124.2011.00113.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There are ethnic differences in HOMA-IR cut-offs and gender variations.

    “Moreover, there are both ethnic differences in cut-offs and gender variations [3,13].”

    From Optimal Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Cut-Offs: A Cross-Sectional Study in the Czech Population (2019) · cites this paper as [3]

    The Discussion reports different HOMA-IR thresholds in Japanese and non-Asian studies and suggests ethnicity might contribute, but cautions that the studies cannot be directly compared without standardized methods. Table 1 in the Results gives slightly different mean HOMA-IR values for men and women; it does not establish gender-specific cut-offs. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. [1]Clinical and Laboratory Standards Institute (CLSI). Defining, Establishing, and Verifying Reference Intervals in the Clinical laboratory; Approved Guideline – Third Edition CLSI document C28‐A3 (ISBN 1‐56238‐682‐4), 2008
  2. [3]Alberti KG, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640– 1645 19805654
  3. [5]WHO. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Consultation. WHO Technical Report Series Number 854. World Health Organization, Geneva, 1995 8594834
  4. [6]WHO Expert Consultation. Appropriate body‐mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157– 163 14726171
  5. [7]Schindhelm RK, Diamant M, Dekker JM, et al. Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006; 22: 437– 443 16832839
  6. [9]Taniguchi A, Fukushima M, Sakai M, et al. Remnant‐like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766– 1769 11128349
  7. [11]Masuo K, Katsuya T, Ogihara T, et al. Acute hyperinsulinemia reduces plasma leptin levels in insulin‐sensitive Japanese men. Am J Hypertens 2005; 18: 235– 243 15752952
  8. [12]Yoshitomi Y, Ishii T, Kaneki M, et al. Relationship between insulin resistance and effect of atorvastatin in non‐diabetic subjects. J Atheroscler Thromb 2005; 12: 9– 13 15725690
  9. [13]Nakai Y, Nakaishi S, Kishimoto H, et al. The threshold value for insulin resistance on homeostasis model assessment of insulin sensitivity. Diabet Med 2002; 19: 346– 347 11943012
  10. [14]Ohnishi H, Saitoh S, Takagi S, et al. Incidence of insulin resistance in obese subjects in a rural Japanese population: the Tanno and Sobetsu study. Diabetes Obes Metab 2004; 7: 83– 87 15642079
  11. [15]Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997; 20: 1562– 1568 9314636
  12. [16]Shimomura H, Maehata E, Kawaguchi T, et al. Trial setting of the insulin resistance index homeostasis model assessment ratio: HOMA‐R reference values for targeting recipients of medical examinations. Seitai Siryo Bunseki 2003; 26: 123– 128 (Japanese).
  13. [17]Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643– 1649 9753305
  14. [18]Ascaso JF, Romero P, Real JT, et al. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non‐diabetic population. Med Clin (Barc) 2001; 117: 530– 533 (Spanish). 11707218
  15. [19]Lee JM, Okumura MJ, Davis MM, et al. Prevalence and determinants of insulin resistance among U.S. adolescents: a population‐based study. Diabetes Care 2006; 29: 2427– 2432 17065679

Cited by

Sorted by citations

Authors
Yamada, C., Mitsuhashi, T., Hiratsuka, N., Inabe, F., Araida, N., & Takahashi, E.
Affiliations
Tokai University (JP)
Corresponding author
Takahashi, Eiko
Venue
Journal of Diabetes Investigation
Publisher
Wiley
Published
2011-04-03
Volume
2
Issue
5
Pages
373-376
ISSN
2040-1116 (ISSN-L)
OpenAlex
W1504450548
Cited by
117
References
3
Citations by year
2026: 12 · 2025: 12 · 2024: 6 · 2023: 7 · 2022: 17 · 2021: 10 · 2020: 7 · 2019: 12 · 2018: 10 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
1.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science (22653079)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
HOMA-IR, insulin resistance, reference values, Japanese population, fasting blood glucose, healthy adults, diagnostic thresholds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review